ARMISTICE CAPITAL, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$71,502,000
+3.0%
10,200,000
+21.8%
1.25%
-7.1%
Q1 2022$69,404,000
+7.1%
8,372,000
-12.5%
1.34%
+26.5%
Q4 2021$64,802,000
+22.3%
9,572,000
-4.3%
1.06%
+18.2%
Q3 2021$53,000,000
-7.8%
10,000,0000.0%0.90%
-12.7%
Q2 2021$57,500,000
+24.7%
10,000,0000.0%1.03%
-2.7%
Q1 2021$46,100,000
+38.0%
10,000,0000.0%1.06%
-6.9%
Q4 2020$33,400,000
+12.5%
10,000,0000.0%1.14%
+5.5%
Q3 2020$29,700,000
+3.7%
10,000,000
+61.3%
1.08%
-14.3%
Q2 2020$28,644,000
+37.8%
6,200,000
+14.8%
1.26%
-2.3%
Q1 2020$20,790,000
+8.7%
5,400,000
+5.9%
1.29%
+16.6%
Q4 2019$19,125,000
-0.4%
5,100,000
+2.0%
1.10%
-8.8%
Q2 2019$19,200,000
+147.7%
5,000,000
+228.9%
1.21%
+185.4%
Q1 2019$7,752,000
+192.5%
1,520,000
+10.1%
0.42%
+110.9%
Q4 2018$2,650,000
-58.1%
1,380,000
-17.5%
0.20%
-47.0%
Q3 2018$6,320,000
+19.2%
1,672,000
-1.6%
0.38%
+9.5%
Q2 2018$5,304,0001,700,0000.35%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders